Amphastar Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amphastar Pharma using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.93 | $0.79 | 17.7 % |
| Q2 | 2025-08-07 | $0.85 | $0.70 | 21.4 % |
| Q1 | 2025-05-07 | $0.74 | $0.69 | 7.25 % |
| Q4 | 2025-02-27 | $0.92 | $0.94 | -2.13 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $191.84M | $184.86M | 3.78 % |
| Q2 | 2025-08-07 | $174.41M | $171.88M | 1.47 % |
| Q1 | 2025-05-07 | $170.53M | $174.91M | -2.51 % |
| Q4 | 2025-02-27 | $186.52M | $188.78M | -1.20 % |
Amphastar Pharma (AMPH) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $0.93, which beat the estimate of $0.79.
The Actual Revenue was $191.8M, which beat the estimate of $184.9M.
Browse earnings estimates, EPS, and revenue on all stocks.